About
Technology
Issues
FAQ
Links
Official Page
Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011).
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.